Patent · US Expired

Integrin receptor antagonists

US5952306A · kind A · utility

5Cited by
11References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 1997
Grant dateSep 14, 1999
Priority date
Expiry dateJan 14, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Fibrinogen receptor antagonists having the formula ##STR1## for example ##STR2## which are useful for inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.